Xanodyne Pharma said that the withdrawal is part of a market-wide withdrawal applying to all propoxyphene-containing products, affecting branded and generic pharmaceutical companies and a number of products
Apricus Bio said that a total of 10 small molecule therapeutic drugs with known low solubility and/or permeability, according to the Biopharmaceuticals (BCS) Classification System, were selected for
Regeneron Pharma and Bayer said that the primary endpoint was statistical non-inferiority in the proportion of patients who maintained (or improved) vision over 52 weeks compared to Ranibizumab.
Data for the analysis were from two Phases of the clinical trial, a double-blind, randomised, relapse-prevention maintenance phase that compared Invega Sustenna to placebo and a one-year open-label
Accolate, an oral prescription medicine used to treat asthma, works by blocking substances in the body called leukotrienes, which may contribute to the asthma symptoms. On 15 November
An IND application clinical hold is an order that the FDA issues to a clinical trial sponsor to postpone approval to conduct a proposed trial pending resolution of
CyDex claimed that the new product is a premixed intravenous (IV) bag formulation of Prism Pharmaceuticals’ Nexterone injection, which was the first CyDex licensed proprietary product to achieve
As per the terms of the agreement, Boehringer Ingelheim will nominate up to seven targets, which may span multiple therapeutic areas, against which the parties will collaborate to
As per the terms of the agreement, Convergence Pharma will apply its ion channel biology platform, medicinal chemistry know-how and preclinical development expertise, recently formed out of GlaxoSmithKline
CTI said that in the current study, patients received PPX with TMZ and RT for six weeks and the main toxicity was grade 4 thrombocytopenia and neutropenia in
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.